Evidence map›Paper›PMID 20653972›Full record

ArticleLipids in health and disease2010

Structured triacylglycerol containing behenic and oleic acids suppresses triacylglycerol absorption and prevents obesity in rats.

Makiko Kojima, Nobuhiko Tachibana, Takashi Yamahira, Satoshi Seino, Ayako Izumisawa, Nobuo Sagi, Toshiharu Arishima, Mitsutaka Kohno, Kiyoharu Takamatsu, Motohiko Hirotsuka and 1 more

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Nervonic acid limits weight gain in a mouse model of diet-induced obesity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Makiko KojimaFood Science Research Institute, Fuji Oil Co., Ltd., 4-3 Kinunodai, Tsukubamirai-shi, Ibaraki 300-2497, Japan. kojima.makiko@so.fujioil.co.jp
Nobuhiko Tachibana
Takashi Yamahira
Satoshi Seino
Ayako Izumisawa
Nobuo Sagi
Toshiharu Arishima
Mitsutaka Kohno
Kiyoharu Takamatsu
Motohiko Hirotsuka
Ikuo Ikeda
Fuji Oil (Japan) · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDietary 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) has been reported to inhibit pancreatic lipase activity in vitro and suppress postprandial hypertriacylglycerolemia in humans. In the present study, the anti-obesity activities of BOO and its inhibitory effects on lymphatic triacylglycerol (TAG) absorption were investigated in rats.

methodsIn Experiment 1, rats were fed either BOO or soybean oil (SO) diet for 6 weeks. In the BOO diet, 20% of SO was replaced with an experimental oil rich in BOO. In Experiments 2 and 3, rats cannulated in the thoracic duct were administered an emulsions containing trioleoylglycerol (OOO) or an oil mixture (OOO:BOO, 9:1). Tri[1-14C]oleoylglycerol (14C-OOO) was added to the emulsions administered in Experiment 3.

resultsNo observable differences were detected in food intake or body weight gain between the BOO and SO groups in Experiment 1. Plasma and liver TAG concentrations and visceral fat weights were significantly lower in the BOO group than in the SO group. The apparent absorption rate of fat was significantly lower in the BOO group than in the SO group. In Experiment 2, the lymphatic recovery of oleic and behenic acids was significantly lower at 5 and 6 h after BOO administration than after OOO administration. In Experiment 3, the lymphatic recovery of 14C-OOO was significantly lower at 5 and 6 h after BOO administration than after OOO administration.

conclusionsThese results suggest that BOO prevents deposition of visceral fat and hepatic TAG by lowering and delaying intestinal absorption of TAG.

Indexed as

Fatty AcidsIntestinal AbsorptionOleic AcidAnimalsAnti-Obesity AgentsCholesterolEatingFat SubstitutesFecesHypertriglyceridemiaIntra-Abdominal FatKineticsLiverLymphLymphatic SystemMaleAnti-Obesity Agentsbehenic acidCholesterolFat SubstitutesFatty AcidsOleic AcidTriglycerides

Identifiers

PMID20653972
PMCPMC2918615
OpenAlexW2147710904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.